• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BonMOLière:小尺寸的现成化合物文库,经过优化,可在蛋白质空间中的各种生物筛选中产生真正的命中化合物。

BonMOLière: Small-Sized Libraries of Readily Purchasable Compounds, Optimized to Produce Genuine Hits in Biological Screens across the Protein Space.

机构信息

Computational Biology Unit (CBU) and Department of Chemistry, University of Bergen, N-5020 Bergen, Norway.

Center for Bioinformatics (ZBH), Department of Informatics, Universität Hamburg, 20146 Hamburg, Germany.

出版信息

Int J Mol Sci. 2021 Jul 21;22(15):7773. doi: 10.3390/ijms22157773.

DOI:10.3390/ijms22157773
PMID:34360558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8346018/
Abstract

Experimental screening of large sets of compounds against macromolecular targets is a key strategy to identify novel bioactivities. However, large-scale screening requires substantial experimental resources and is time-consuming and challenging. Therefore, small to medium-sized compound libraries with a high chance of producing genuine hits on an arbitrary protein of interest would be of great value to fields related to early drug discovery, in particular biochemical and cell research. Here, we present a computational approach that incorporates drug-likeness, predicted bioactivities, biological space coverage, and target novelty, to generate optimized compound libraries with maximized chances of producing genuine hits for a wide range of proteins. The computational approach evaluates drug-likeness with a set of established rules, predicts bioactivities with a validated, similarity-based approach, and optimizes the composition of small sets of compounds towards maximum target coverage and novelty. We found that, in comparison to the random selection of compounds for a library, our approach generates substantially improved compound sets. Quantified as the "fitness" of compound libraries, the calculated improvements ranged from +60% (for a library of 15,000 compounds) to +184% (for a library of 1000 compounds). The best of the optimized compound libraries prepared in this work are available for download as a dataset bundle ("BonMOLière").

摘要

实验筛选针对大分子靶标的大量化合物是识别新生物活性的关键策略。然而,大规模筛选需要大量的实验资源,并且耗时且具有挑战性。因此,具有高几率在任意感兴趣的蛋白质上产生真实命中的中小规模化合物库对于与早期药物发现相关的领域(特别是生化和细胞研究)将具有巨大价值。在这里,我们提出了一种计算方法,该方法结合了药物相似性、预测的生物活性、生物空间覆盖度和靶标新颖性,以生成具有最大几率产生广泛蛋白质的真实命中的优化化合物库。该计算方法使用一组既定规则评估药物相似性,使用经过验证的基于相似性的方法预测生物活性,并优化小化合物集的组成,以实现最大的靶标覆盖率和新颖性。我们发现,与随机选择化合物库相比,我们的方法生成了明显改进的化合物集。作为化合物库的“适应性”进行量化,计算出的改进幅度从+60%(对于 15000 个化合物的库)到+184%(对于 1000 个化合物的库)不等。在这项工作中准备的最佳优化化合物库可作为数据集捆绑包(“BonMOLière”)下载。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/22a5da7e11a1/ijms-22-07773-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/c9d6b8a75018/ijms-22-07773-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/f235d54ac14b/ijms-22-07773-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/4f80950cd547/ijms-22-07773-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/9ecf0b3e67ad/ijms-22-07773-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/f57642dbba4f/ijms-22-07773-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/80f397931d8c/ijms-22-07773-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/2a85db3468c0/ijms-22-07773-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/d98ac3df1b18/ijms-22-07773-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/89e84c2d526c/ijms-22-07773-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/f1c6f4249772/ijms-22-07773-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/22a5da7e11a1/ijms-22-07773-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/c9d6b8a75018/ijms-22-07773-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/f235d54ac14b/ijms-22-07773-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/4f80950cd547/ijms-22-07773-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/9ecf0b3e67ad/ijms-22-07773-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/f57642dbba4f/ijms-22-07773-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/80f397931d8c/ijms-22-07773-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/2a85db3468c0/ijms-22-07773-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/d98ac3df1b18/ijms-22-07773-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/89e84c2d526c/ijms-22-07773-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/f1c6f4249772/ijms-22-07773-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d1/8346018/22a5da7e11a1/ijms-22-07773-g011.jpg

相似文献

1
BonMOLière: Small-Sized Libraries of Readily Purchasable Compounds, Optimized to Produce Genuine Hits in Biological Screens across the Protein Space.BonMOLière:小尺寸的现成化合物文库,经过优化,可在蛋白质空间中的各种生物筛选中产生真正的命中化合物。
Int J Mol Sci. 2021 Jul 21;22(15):7773. doi: 10.3390/ijms22157773.
2
Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.用于药物筛选的市售化合物库的类药性和疏水性增加。
Curr Top Med Chem. 2012;12(14):1500-13. doi: 10.2174/156802612802652466.
3
The Screening Compound Collection: A Key Asset for Drug Discovery.筛选化合物库:药物发现的关键资产。
Chimia (Aarau). 2017 Oct 25;71(10):667-677. doi: 10.2533/chimia.2017.667.
4
Development and Testing of Druglike Screening Libraries.药物筛选库的开发与测试。
J Chem Inf Model. 2019 Jan 28;59(1):53-65. doi: 10.1021/acs.jcim.8b00537. Epub 2019 Jan 3.
5
DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.DNA 编码化学文库:超越传统小分子文库。
Acc Chem Res. 2014 Apr 15;47(4):1247-55. doi: 10.1021/ar400284t. Epub 2014 Mar 28.
6
Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.基于诺华内部高通量筛选数据的逐步化合物选择的迭代筛选分析
ACS Chem Biol. 2016 May 20;11(5):1255-64. doi: 10.1021/acschembio.6b00029. Epub 2016 Feb 26.
7
Bead-based screening in chemical biology and drug discovery.基于珠粒的筛选在化学生物学和药物发现中的应用。
Chem Commun (Camb). 2018 Jun 19;54(50):6759-6771. doi: 10.1039/c8cc02486c.
8
Cheminformatics approaches to analyze diversity in compound screening libraries.化学信息学方法分析化合物筛选库中的多样性。
Curr Opin Chem Biol. 2010 Jun;14(3):325-30. doi: 10.1016/j.cbpa.2010.03.017. Epub 2010 Apr 22.
9
Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.小分子文库子集筛选助力加速先导化合物鉴定
J Biomol Screen. 2014 Jun;19(5):758-70. doi: 10.1177/1087057114522515. Epub 2014 Feb 11.
10
Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.从两个类先导化合物库的性能分析中定位筛选命中的最佳点和评估通用分析干扰滤光片。
J Chem Inf Model. 2013 Mar 25;53(3):534-44. doi: 10.1021/ci300382f. Epub 2013 Mar 4.

引用本文的文献

1
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery.探索评分函数空间:开发药物发现的计算模型。
Curr Med Chem. 2024;31(17):2361-2377. doi: 10.2174/0929867330666230321103731.

本文引用的文献

1
An open source chemical structure curation pipeline using RDKit.一个使用RDKit的开源化学结构编目流程。
J Cheminform. 2020 Sep 1;12(1):51. doi: 10.1186/s13321-020-00456-1.
2
The chemfp project.化学指纹项目。
J Cheminform. 2019 Dec 5;11(1):76. doi: 10.1186/s13321-019-0398-8.
3
PubChem in 2021: new data content and improved web interfaces.PubChem 在 2021 年:新增数据内容和改进的网络界面。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395. doi: 10.1093/nar/gkaa971.
4
Evolution of Novartis' Small Molecule Screening Deck Design.诺华小分子筛选库设计的演变。
J Med Chem. 2020 Dec 10;63(23):14425-14447. doi: 10.1021/acs.jmedchem.0c01332. Epub 2020 Nov 3.
5
Pfam: The protein families database in 2021.Pfam:2021 年的蛋白质家族数据库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419. doi: 10.1093/nar/gkaa913.
6
ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery.ZINC20-A 免费超大尺度化学数据库,用于配体发现。
J Chem Inf Model. 2020 Dec 28;60(12):6065-6073. doi: 10.1021/acs.jcim.0c00675. Epub 2020 Oct 29.
7
Similarity-Based Methods and Machine Learning Approaches for Target Prediction in Early Drug Discovery: Performance and Scope.基于相似度的方法和机器学习方法在早期药物发现中的靶标预测:性能和范围。
Int J Mol Sci. 2020 May 19;21(10):3585. doi: 10.3390/ijms21103585.
8
Diversity & tractability revisited in collaborative small molecule phenotypic screening library design.在合作小分子表型筛选库设计中重新探讨多样性和可处理性。
Bioorg Med Chem. 2020 Jan 1;28(1):115192. doi: 10.1016/j.bmc.2019.115192. Epub 2019 Nov 20.
9
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.定量构效关系(QSAR)与共形预测方法的大规模比较及其在药物发现中的应用。
J Cheminform. 2019 Jan 10;11(1):4. doi: 10.1186/s13321-018-0325-4.
10
The Pfam protein families database in 2019.2019 年 Pfam 蛋白质家族数据库。
Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432. doi: 10.1093/nar/gky995.